AFP and hepatocellular carcinoma: Serum biomarkers beyond AFP, such as protein induced by vitamin K absence II (PIVKA-II), also known as des-gamma-carboxy prothrombin (DCP), are particularly valuable for identifying HCC in AFP-negative patients and demonstrate comparable or slightly superior sensitivity to AFP for detecting early-stage disease [50,51].